APA (7th ed.) Citation

M, Z., J, J., M, F., S, A. D., R, M., AW, L., . . . A, A. (2025). Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus. Human vaccines & immunotherapeutics, 21(1), 2523106. https://doi.org/10.1080/21645515.2025.2523106

Chicago Style (17th ed.) Citation

M, Zayed, et al. "Budget Impact of Maternal Vaccination with RSVpreF to Protect Privately Insured Infants in Dubai Against Respiratory Syncytial Virus." Human Vaccines & Immunotherapeutics 21, no. 1 (2025): 2523106. https://doi.org/10.1080/21645515.2025.2523106.

MLA (9th ed.) Citation

M, Zayed, et al. "Budget Impact of Maternal Vaccination with RSVpreF to Protect Privately Insured Infants in Dubai Against Respiratory Syncytial Virus." Human Vaccines & Immunotherapeutics, vol. 21, no. 1, 2025, p. 2523106, https://doi.org/10.1080/21645515.2025.2523106.